ProPep Surgical has announced it has received FDA clearance for its ProPep nerve monitoring system, according to a news release.
The ProPep system is specifically designed for use during robotic surgery. It is intended to allow surgeon to do intraoperative nerve monitoring during minimally invasive, robotic-assisted surgery for prostate cancer.
The system helps surgeons make a more informed decision about which nerve tissue to selectively preserve or remove during an operation, and also assess the integrity of the nerve during the procedure, according to the release.
ProPep Surgical is headquartered in Austin, Texas.
Related Articles on FDA Clearances:
Ultrasonix Medical Receives FDA Approval for Needle Guidance Technology
Synergetics Receives FDA Clearance for Versavit Vitrectomy System
FDA Approves First Glaucoma Stent for Cataract Surgery